促甲状腺激素与游离甲状腺素的年龄特异性参考区间以优化甲状腺疾病诊断
该多中心回顾性横断面研究基于13家荷兰实验室2008—2022年数据,用TMC和refineR分析在四种免疫分析平台上建立促甲状腺激素(TSH)和游离甲状腺素(FT4)的年龄特异性参考区间(RI)。结果显示儿童期TSH上限和FT4下限较高、成年后下降;采用成人年龄特异性RI后,Roche数据集中50岁以上女性和60岁以上男性亚临床及临床甲减诊断减少。作者认为应强烈考虑实施成人TSH年龄特异性RI,FT4年龄特异性RI数据尚不一致、需更多研究。
要点
- 儿童期TSH上限和FT4下限较高,随成年下降。
- 成人TSH上限男性从60岁、女性从50岁起升高,FT4上限从70岁起升高。
- 采用成人年龄特异性RI可减少Roche数据集中老年亚临床甲减诊断。
核心结论
- 研究强调儿童使用TSH和FT4年龄特异性参考区间的重要性。
- 研究显示成人使用TSH年龄特异性参考区间可减少老年人亚临床甲减诊断,具有临床相关性。
- 作者认为应强烈考虑实施成人TSH年龄特异性参考区间。
- FT4年龄特异性参考区间数据较不一致,实施于临床实践前需更多研究。
研究设计与样本
- 多中心回顾性横断面研究,利用大数据确定TSH和FT4的间接参考区间(RI)。
- TSH的RI由TMC分析确定,FT4的RI由refineR分析确定。
- 使用Roche、Abbott、Siemens和Beckman Coulter四种免疫分析平台,按制造商分别评估RI。
- 回顾性数据(2008—2022年)来自13家荷兰实验室,服务对象为全科医生和当地医院。
- 年龄分组:2至20岁按2岁类别,20至100岁按十年类别。
主要发现
- TSH上限和FT4下限在幼儿期较高,向成年期下降。
- 成年期TSH上限男性从60岁起升高、女性从50岁起升高,FT4上限从70岁起升高。
- 在Roche数据集中,使用成人年龄特异性RI后,50岁以上女性和60岁以上男性亚临床及临床甲减诊断减少。
关键数值与推荐
- TSH参考区间由TMC分析确定,FT4参考区间由refineR分析确定,按Roche、Abbott、Siemens和Beckman Coulter各制造商分别评估。
- 年龄分组为2至20岁每2岁一类、20至100岁每十年一类。
- 作者认为应强烈考虑实施成人TSH年龄特异性参考区间。
- FT4年龄特异性参考区间在临床实施前需更多研究。
临床怎么用
- 作者认为应强烈考虑实施成人TSH年龄特异性参考区间以减少老年人亚临床甲减诊断。
- 作者指出FT4年龄特异性参考区间数据较不一致,实施于临床实践前需更多研究。
局限性
- FT4年龄特异性参考区间数据较不一致,实施于临床实践前需更多研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Thyroid-stimulating hormone (TSH) and subsequent free thyroxine (FT4) concentrations outside the reference interval (RI) are used to diagnose thyroid diseases. Most laboratories do not provide age-specific RIs for TSH and FT4 beyond childhood, although TSH concentrations vary with age. Therefore, we aimed to establish TSH and FT4 age-specific RIs throughout life and aimed to determine whether using these RIs would result in reclassification of thyroid disease diagnoses in adults. Methods: This multicenter retrospective cross-sectional study used big data to determine indirect RIs for TSH and FT4. These RIs were determined by TMC and refineR-analysis, respectively, using four different immunoassay platforms (Roche, Abbott, Siemens, and Beckman Coulter). Retrospective data (2008-2022) from 13 Dutch laboratories for general practitioners and local hospitals were used. RIs were evaluated per manufacturer. Age groups were established from 2 to 20 years by 2-year categories and decade categories between 20 and 100 years. Results: We included totally 7.6 million TSH and 2.2 million FT4 requests. TSH upper reference limits (URLs) and FT4 lower reference limits were higher in early childhood and decreased toward adulthood. In adulthood, TSH URLs increased from 60 years in men, and from 50 years in women, while FT4 URLs increased from 70 years onward. Using adult age-specific RIs resulted in a decrease in diagnoses of subclinical and overt hypothyroidism in women above 50 and men above 60 years in our Roche dataset. Conclusion: This study stressed the known importance of using age-specific RIs for TSH and FT4 in children. This study also showed the clinical relevance of using age-specific RIs for TSH in adulthood to reduce diagnoses of subclinical hypothyroidism in older persons. Therefore, implementation of adult TSH age-specific RIs should be strongly considered. Data are less uniform regarding FT4 age-specific RIs and more research should be performed before implementing these in clinical practice.
引用
- Jansen HI, Dirks NF, Hillebrand JJ, et al. Age-Specific Reference Intervals for Thyroid-Stimulating Hormones and Free Thyroxine to Optimize Diagnosis of Thyroid Disease. Thyroid. 2024. PMID: 39283820. doi:10.1089/thy.2024.0346
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。